Meanwhile, our findings showed that the treatment of drug combination can more significantly enhance the activity of autophagy than that of each reagent, and the inhibition of autophagy using genetic or pharmacological methods can further improve the anti-tumor efficacy of a combination of ATO with PTL. This evidence concerns the gene PNLIP and neoplasm.